Soleno Therapeutics, Inc.
NASDAQ:SLNO
52.73 (USD) • At close September 19, 2024
Overview | Financials
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operationele Activiteiten: | ||||||||||||
| Nettowinst
| -38.988 | -24.067 | -30.91 | -24.639 | -30.774 | -11.841 | -12.074 | -12.065 | -15.909 | -13.875 | -3.707 | -6.482 |
| Afschrijvingen & Amortisatie
| 1.958 | 1.964 | 1.963 | 1.954 | 1.958 | 1.963 | 1.611 | 0.132 | 0.108 | 0.029 | 0.042 | 0.044 |
| Uitgestelde Inkomstenbelasting
| -1.372 | 0 | -0.508 | -11.637 | 6.964 | -3.877 | -1.651 | 0.022 | 3.565 | 4.586 | 0.107 | 0.022 |
| Aandelen Gebaseerde Vergoedingen
| 5.945 | 2.53 | 3.276 | 1.5 | 0.825 | 0.988 | 0.88 | 0.871 | 0.942 | 0.345 | 0.038 | 0.024 |
| Verandering in Werkkapitaal
| 2.928 | -0.756 | -1.148 | 2.975 | 2.499 | 0.082 | -0.024 | -0.815 | 0.81 | 0.3 | -0.226 | 0.029 |
| Vorderingen
| 0 | 0 | 0 | 0 | 0.064 | -0.064 | 0 | 0.023 | -0.156 | 0.15 | -0.15 | 0 |
| Voorraden
| 0 | 0 | 0 | 0 | -0.064 | 0 | 0 | -0.109 | -0.442 | -0.109 | 12.741 | 0 |
| Crediteuren
| 1.372 | -1.477 | -0.235 | 1.494 | 1.061 | 0.249 | 0.191 | -0.149 | 0.212 | 0.354 | -0.162 | 0.045 |
| Overig Werkkapitaal
| 1.556 | 0.721 | -0.913 | 1.481 | 1.438 | -0.167 | -0.215 | -0.58 | 1.196 | -0.094 | -12.655 | -0.017 |
| Overige Niet-Contante Posten
| 4.589 | -0.452 | -0.443 | 4.623 | 1.153 | 1.002 | 1.308 | -1.642 | 0.183 | 4.13 | 2.86 | 2.866 |
| Kasstroom uit Operationele Activiteiten
| -24.94 | -20.781 | -27.77 | -25.224 | -17.375 | -11.683 | -9.95 | -13.498 | -10.299 | -4.484 | -0.885 | -3.496 |
| Investeringsactiviteiten: | ||||||||||||
| Investeringen in Materiële Vaste Activa
| 0 | -0.013 | -0.022 | -0.007 | -0.021 | -0.008 | -0.003 | -0.039 | -0.306 | -0.031 | -0.001 | -0.002 |
| Netto Overnames
| 0 | 0 | 0 | 0 | 0.5 | 0 | -0.573 | 0 | -1 | 0 | 0 | 0 |
| Aankoop van Beleggingen
| 0 | 0 | 0 | 0 | -0.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Verkoop/verval van Beleggingen
| 0 | 0 | 0 | 0 | 0.5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Investeringsactiviteiten
| 0 | 0 | 0 | 0 | 0.049 | -0.172 | 0.954 | -0.024 | -0.015 | 0 | 0 | 0 |
| Kasstroom uit Investeringsactiviteiten
| 0 | -0.013 | -0.022 | -0.007 | 0.528 | -0.18 | 0.379 | -0.039 | -1.321 | -0.031 | -0.001 | -0.002 |
| Financieringsactiviteiten: | ||||||||||||
| Schuldaflossingen
| 0 | 0 | -0.008 | -0.017 | -0.002 | 0 | 0 | 0 | -0.102 | 0 | 0 | 0 |
| Uitgifte van Gewone Aandelen
| 180.019 | 15.152 | 0 | 53.722 | 14.483 | 16.5 | 25.008 | -7,780 | 1.434 | 10.727 | 0 | 0.028 |
| Terugkoop van Gewone Aandelen
| 0 | -0 | -0 | 0 | 0 | 0 | 0 | -7.78 | 0 | 0 | 0 | 0 |
| Uitgekeerde Dividenden
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Overige Financieringsactiviteiten
| 42.162 | -1.06 | -0.12 | 0.017 | 0.014 | 1.327 | -1.063 | 7,798.548 | 7.825 | 0.476 | 0 | 4.999 |
| Kasstroom uit Financieringsactiviteiten
| 180.019 | 14.092 | -0.128 | 53.722 | 14.481 | 17.827 | 23.945 | 10.768 | 9.158 | 11.203 | 0 | 5.027 |
| Overige Informatie: | ||||||||||||
| Effect van Wisselkoersveranderingen op Kas
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Netto Kasstroomverandering
| 155.079 | -6.702 | -27.92 | 28.491 | -2.366 | 5.964 | 14.374 | -2.769 | -2.462 | 6.688 | -0.886 | 1.528 |
| Kaspositie aan het Einde van de Periode
| 169.681 | 14.602 | 21.304 | 49.224 | 20.733 | 23.099 | 17.1 | 2.726 | 5.495 | 7.957 | 1.269 | 2.155 |